Alivexis, Inc.
- Biotech or pharma, therapeutic R&D
Alivexis, formerly Modulus Discovery, is a small molecule drug discovery company with a proprietary fast and accurate simulation + AI platform that enables efficient discovery of clinical candidates in the areas of oncology and immunology.
Roy Kimura, Co-founder and CEO, will be presenting recent developments for the company's pipeline & platform on Tuesday, June 17 at 3:30 PM in Room 153C at the BIO International Convention.